Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fine Chemical Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112479948A details a novel NHC-catalyzed asymmetric Michael addition for beta-sulfonyl chiral amines, offering metal-free synthesis and high enantioselectivity for pharmaceutical intermediates.
Patent CN113527077A details a novel anisole-based route for anisyl propionaldehyde, offering significant cost reduction and high purity for the fragrance industry.
Patent CN114105780A details a cost-effective one-pot synthesis of isooctylamine from n-butyraldehyde using skeletal nickel, offering significant supply chain advantages.
Patent CN108026007A reveals Mo-doped Raney Ni catalyst for high-purity diol synthesis. Enables cost reduction in synthetic flavors manufacturing with safer moderate conditions.
Novel two-step palladium-catalyzed method for polysubstituted 2-naphthols using CO and allyltin. Offers cost reduction and scalability for pharmaceutical intermediates.
Discover the palladium-catalyzed synthesis of Sila-Dehydroherbalone. A high-purity fragrance intermediate offering cost reduction and scalable supply chain solutions.
Patent CN102531925A reveals a clean catalytic hydrogenation route for 1-aminoanthraquinone, offering >99% purity and eliminating toxic sulfur waste for cost-effective dye intermediate manufacturing.
Discover a novel preparation method for N-phenyl bis(trifluoromethanesulfonyl) imide using trifluoromethanesulfonyl fluoride. Achieve high purity and significant cost reduction.
Patent CN109336825A reveals stabilized mother liquor recycling for 5-ABI. High purity pigment intermediate. Significant cost reduction and supply reliability.
Patent CN106565439A enables one-step 9-fluorenone synthesis. Achieves 99.7% purity without water washing. Significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN108948059B reveals solvent-free boronation using Mg catalysts. Reduces cost and toxicity for high-purity pharmaceutical intermediates manufacturing.
Novel sulfonic acid resin catalyzed esterification ensures high purity and reduced corrosion for reliable methyl p-tert-butylbenzoate supply chain optimization.
Patent CN111825716B reveals efficient Cu-catalyzed route for naphthoxazole phosphine oxides, offering cost-effective ligand manufacturing solutions.
Patent CN111809195B details a green electrochemical route for alpha-disulfide dicarboxylic acids, offering significant cost reduction and scalability for pharmaceutical intermediates.
Patent CN105492606A enables efficient (-)-vibo-quercitol production via novel reductase, offering high purity and cost reduction for pharma intermediates.
Patent CN1269950C details a novel biotechnological process for preparing amides using Amycolatopsis and Rhodococcus strains, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113292517A reveals a mild anion exchange resin method for shikimic acid epoxide synthesis, offering 98-100% yield and enhanced supply chain safety.
Patent CN1435408A reveals a cost-effective one-step hydrogenation route for beta-amino acids. Discover scalable manufacturing advantages for pharmaceutical intermediates.
Patent CN1266904A details a lipase-catalyzed process for high-purity stereoisomer carboxylates, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN101302216B details a non-toxic decarboxylation method for 5-HT3 antagonist intermediates, replacing hazardous chromium and tin reagents with safe chloride salts for scalable manufacturing.